ArticleArthritis research & therapy2021

Switching from TNFα inhibitor to tacrolimus as maintenance therapy in rheumatoid arthritis after achieving low disease activity with TNFα inhibitors and methotrexate: 24-week result from a non-randomized, prospective, active-controlled trial.

Sang Youn Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.